1 Min Read
July 31 (Reuters) - Teva Pharmaceutical Industries Ltd said:
* Sees 2014 revenue $19.5-$20.5 billion with Copaxone competition versus previous estimate $19.3-$20.3 billion Further company coverage: (Reporting by Tova Cohen)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.